Research map: Statins Ticagrelor and Rhabdomyolysis: A Coincidence or a Drug Interaction?

Back to the article

Papers in this map

  1. Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management · Erik S.G. Stroes · 2015 · 1453 citations · Cited by this paper
  2. Ticagrelor and Statins: Dangerous Liaisons? · Bianca Rocca · 2024 · 9 citations · Cites this paper
  3. Deep Appreciation to Our Reviewers in the Past Year 2025 · 2026 · Related
  4. Statin-Associated Side Effects · Paul D. Thompson · 2016 · 752 citations · Cited by this paper
  5. Oral P2Y12 Inhibitors: Victims or Perpetrators? A Focused Review on Pharmacokinetic, Clinically Relevant Drug Interactions · Elisabetta Bigagli · 2025 · 9 citations · Cites this paper
  6. Fatty Acids in Childhood Obesity: A Link Between Nutrition, Metabolic Alterations and Cardiovascular Risk · 2025 · Related
  7. An assessment by the Statin Muscle Safety Task Force: 2014 update · Robert S. Rosenson · 2014 · 488 citations · Cited by this paper
  8. Ticagrelor is Associated with Increased Rosuvastatin Blood Concentrations in Patients who have had a Myocardial Infarction · Tjaša Dermota · 2025 · 5 citations · Cites this paper
  9. Association Between Lipid-Lowering Drug Use and Sarcopenia: Analysis of the Korea National Health and Nutrition Examination Survey · 2026 · Related
  10. Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment · E LEE · 2005 · 482 citations · Cited by this paper
  11. 2024 KSoLA Update on New Lipid-Lowering Agents: Inclisiran and Bempedoic Acid · Hack‐Lyoung Kim · 2025 · 4 citations · Cites this paper
  12. Practical Approaches to Managing Dyslipidemia in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease · 2025 · Related
  13. Safety and Efficacy of Statins in Asians · James K. Liao · 2006 · 272 citations · Cited by this paper
  14. Letter by Isa Ardahanli Regarding Article, Statins Ticagrelor and Rhabdomyolysis: A Coincidence or a Drug Interaction? · İsa Ardahanlı · 2025 · 3 citations · Cites this paper
  15. Triglycerides, Triglyceride-Rich Lipoproteins, and Remnant Cholesterol in Atherosclerotic Cardiovascular Disease · 2025 · Related
  16. Clinical Perspectives of Statin-Induced Rhabdomyolysis · Kenneth Antons · 2006 · 240 citations · Cited by this paper
  17. Escalating Lipid Therapy After Achieving LDL-C <70 mg/dL With Moderate-Intensity Statins in High-Risk Patients · Geunhee Park · 2024 · 2 citations · Cites this paper
  18. Investigation of the Influence of Lipoprotein(a) and Oxidized Lipoprotein(a) on Plasminogen Activation and Fibrinolysis · 2025 · Related
  19. New insights into mechanisms of statin-associated myotoxicity · Pascal Sirvent · 2008 · 191 citations · Cited by this paper
  20. Exercise-induced mild rhabdomyolysis associated with oclacitinib in a dog · Junya Hirashima · 2025 · 1 citation · Cites this paper
  21. NLA scientific statement on statin intolerance: a new definition and key considerations for ASCVD risk reduction in the statin intolerant patient · Mary Katherine Cheeley · 2022 · 190 citations · Cited by this paper
  22. Possible clinical drug interactions between ticagrelor and concomitant medications: for adverse drug event monitoring in real-world · Tianya Liu · 2026 · Cites this paper
  23. Statin-Induced Rhabdomyolysis: A Comprehensive Review of Case Reports · Polyana Leite Mendes · 2013 · 117 citations · Cited by this paper
  24. Fatal Rhabdomyolysis after Rosuvastatin Dose Modification in Acute Coronary Syndrome: A Case Report · Taiana Alekseevna Makarova · 2025 · Cites this paper
  25. Assessment and management of statin-associated muscle symptoms (SAMS): A clinical perspective from the National Lipid Association · Bruce A. Warden · 2022 · 112 citations · Cited by this paper
  26. Management of a patient with a ticagrelor–rosuvastatin interaction: An algorithm-based tool kit for pharmacists · Keren-Happauch Emekeme · 2026 · Cites this paper
  27. Assessment of the Risk of Rhabdomyolysis and Myopathy During Concomitant Treatment with Ticagrelor and Statins · Dorota Danielak · 2018 · 44 citations · Cited by this paper
  28. Response to Letter Regarding Article, Statins Ticagrelor and Rhabdomyolysis: A Coincidence or a Drug Interaction? · Jai Bharat Sharma · 2025 · Cites this paper
  29. Statin Effects on LDL and HDL Cholesterol in South Asian and White Populations · Milan Gupta · 2009 · 35 citations · Cited by this paper
  30. Time trends analysis of statin prescription prevalence, therapy initiation, dose intensity, and utilization from the hospital information system of Jinshan Hospital, Shanghai (2012–2018) · Yujuan Liu · 2020 · 29 citations · Cited by this paper
  31. Rosuvastatin‐Induced Rhabdomyolysis – Possible Role of Ticagrelor and Patients’ Pharmacogenetic Profile · Majda Vrkić Kirhmajer · 2018 · 28 citations · Cited by this paper
  32. Prevalence of genetic variants associated with cardiovascular disease risk and drug response in the Southern Indian population of Kerala · Changanamkandath Rajesh · 2014 · 26 citations · Cited by this paper
  33. Ticagrelor-induced renal failure leading to statin-induced rhabdomyolysis. · Annelies J. van Vuren · 2015 · 25 citations · Cited by this paper
  34. Effects of statins on nitric oxide/cGMP signaling in human umbilical vein endothelial cells · Claudia Meda · 2010 · 24 citations · Cited by this paper
  35. Ticagrelor and Statin Interaction Induces Rhabdomyolysis and Acute Renal Failure: Case reports and Scoping Review · Pramod Theetha Kariyanna · 2019 · 19 citations · Cited by this paper
  36. The Interaction Between Rosuvastatin and Ticagrelor Leading to Rhabdomyolysis: A Case Report and Narrative Review · Rachel A. Sibley · 2020 · 11 citations · Cited by this paper
  37. The epidemic of atherosclerotic cardiovascular disease in India · Paul Barton Duell · 2020 · 8 citations · Cited by this paper
  38. Fracaso renal agudo secundario a rabdomiólisis en paciente en tratamiento con ticagrelor y atorvastatina · Juan A. Martín Navarro · 2019 · 2 citations · Cited by this paper

Source: OpenAlex (CC0)